AstraZeneca to acquire vaccine maker Icosavax for up to $1.1B
Bio Pharma Dive
DECEMBER 12, 2023
The deal signals the pharma company’s continuing interest in vaccine development and hands it a combination shot aimed at two respiratory viruses.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Bio Pharma Dive
DECEMBER 12, 2023
The deal signals the pharma company’s continuing interest in vaccine development and hands it a combination shot aimed at two respiratory viruses.
World of DTC Marketing
JANUARY 8, 2021
SUMMARY: Pfizer and Moderna will sell $28 billion of Covid-19 vaccines this year. Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others. So far the winners are Pfizer and Moderna.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
JULY 28, 2020
QUICK READ : Pharma had a chance to earn some goodwill with a very skeptical public but it’s become obvious that the rush to develop a vaccine is about profit, executive stock, and Wall Street despite potential huge investments from the government. Moderna, a 10-year-old vaccine developer based in Cambridge, Mass.,
World of DTC Marketing
JULY 22, 2020
QUICK READ : The government is agreeing to pay billions of dollars to the first company that developed a COVID-19 vaccine. billion for 100 million doses of a vaccine made by Pfizer Inc. The question that the media is asking is “will consumers trust a COVID-19 vaccine?” health officials agreed to pay $1.95
World of DTC Marketing
AUGUST 3, 2020
QUICK READ: As COVID-19 vaccines enter Phase III trials one has to wonder just how transparent pharma companies will be with the data. Personally I would want to know as much as I can before I ask for the vaccine but I also know that greed can make people do stupid things and there is a lot of money at stake here.
World of DTC Marketing
FEBRUARY 28, 2021
SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Can a COVID-19 vaccine approval suddenly erase that? billion in penalties.
pharmaphorum
FEBRUARY 9, 2022
In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. A broad front.
pharmaphorum
APRIL 19, 2021
The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS.
Pharmaceutical Technology
NOVEMBER 15, 2022
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This also has clear advantages in healthcare settings, particularly when it comes to vaccines. In general, a prefilled syringe is clearly preferred for vaccines.”. A new challenge .
pharmaphorum
NOVEMBER 29, 2021
The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale. It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.
pharmaphorum
OCTOBER 7, 2021
Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. of Africans have been fully vaccinated against COVID-19, and just 15 African nations have met the agency’s objective of 10% coverage.
pharmaphorum
DECEMBER 16, 2022
Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Further, with a pandemic treaty in development, there are reasons to believe that many countries and the WHO want to see a more equitable distribution of medical products for future pandemics.
pharmaphorum
MARCH 24, 2021
The Prime Minister reportedly told Conservative backbench MPs on a Zoom call that “capitalism” and “greed” was behind the success of the UK’s COVID-19 vaccination programme, before backtracking after realising he had made a blunder and telling attendees to forget the comments. " But he’s wrong.
pharmaphorum
AUGUST 23, 2021
The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting emergency use authorisation in India. Proponents of the approach claim that DNA vaccines may have advantages over other technologies like mRNA.
The Pharma Data
DECEMBER 20, 2020
UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.
BioPharma Reporter
JANUARY 28, 2022
Contract development and manufacturing organization (CDMO), Recipharm, says it has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France.
World of DTC Marketing
NOVEMBER 27, 2020
SUMMARY: Business by press release has made pharma executives a lot of money but we still haven’t seen any over reviewed data on COVID 19 vaccines. The American Nurses Association, a national professional organization, said one-third of its members do not intend to take the vaccine, and an additional third are undecided.
pharmaphorum
FEBRUARY 24, 2021
The FDA has issued guidelines allowing for faster development of updated coronavirus vaccines, based on previously approved shots that have been tweaked to combat emerging variants of the SARS-CoV-2 virus. If vaccines need updating, the FDA expects that manufacturing information will remain generally the same.
World of DTC Marketing
SEPTEMBER 23, 2021
SUMMARY: Pfizer will earn over 26 billion dollars from their COVID vaccine, while Moderna and J&J also look to their vaccines for more profit dollars. Here is his rationale: “ When we asked the Pfizer colleagues to develop a Covid-19 vaccine in l ess than a year, you did. trillion social spending package.
pharmaphorum
FEBRUARY 14, 2022
Seattle, US vaccine startup Curevo has raised $60 million in first-round financing that it says will be used to run head-to-head trials of its experimental shingles vaccines CRV-101 and GlaxoSmithKline’s market-leading Shingrix. The biotech has been looking for a development partner for the shot as a chickenpox vaccine.
pharmaphorum
MARCH 2, 2022
Pfizer’s vaccine for Clostridium difficile (C. The pharma company was quick to point out however that the CLOVER trial of PF-06425090 was undermined by a lower-than expected rate of C. With no approved vaccines to date, C. As it stands, PF-06425090 is still leading the field among candidate vaccines for C.
Pharmaceutical Technology
AUGUST 1, 2022
Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.
pharmaphorum
JULY 15, 2022
In the final piece of a three-part series, Ben Hargreaves explores how manufacturing infrastructure was rapidly built up to the required capacity to ensure sufficient supply of COVID-19 vaccines, and what still remains to be done to improve vaccine equity globally. All angles.
Delveinsight
JULY 29, 2020
Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus. Several pharma and biotech companies are developing and manufacturing safe and effective vaccines to fight coronavirus.
Drug Discovery World
DECEMBER 7, 2022
The programme is aimed at organisations seeking to develop leadership and mentoring skills and promote diversity in the life sciences work environment. We are excited to open up the waitlist for the next stage, and encourage people from other backgrounds to get involved, including our tech company members.” .
Pharmaceutical Technology
JANUARY 16, 2023
Recent cases in the pharmaceutical sector include Poolbeg Pharma finding more than one respiratory syncytial virus (RSV) vaccine candidate with AI by going through a vast amount of early stage clinical data to prioritise candidates and reposition them as novel treatments for RSV infection.
World of DTC Marketing
APRIL 20, 2021
With medical visits picking up again among patients vaccinated against covid-19, health providers are starting to see the consequences of a year of pandemic-delayed preventive and emergency care as they find more advanced cancer and rotting and damaged teeth, among other ailments. Pfizer could sell $24 billion in Covid Vaccine this year.
World of DTC Marketing
FEBRUARY 4, 2021
Misuse Federal Data to Falsely Claim COVID Vaccines Are Dangerous. The national vaccine safety surveillance program run by the Centers for Disease Control and Prevention (CDC) and the U.S. Established anti-vaccine activists and groups are newly interested in mining VAERS data to suggest that matters are even worse than what it shows.
The Pharma Data
DECEMBER 4, 2020
After an incredible milestone for science, this week we bring our readers news from Pfizer and BioNTech on the promise of a Covid-19 vaccine result. Pfizer and BioNTech achieve first authorization use for their Covid-19 vaccine in the UK. Our aim is to bring a safe and effective vaccine upon approval to the people who need it.
World of DTC Marketing
MARCH 1, 2021
Pharma has to undress, and that trust is an ongoing process, and leaders cannot rest on the work they have completed, like developing vaccines. The employees at J&J are saying, on LinkedIn, how proud they are that their company developed a COVID vaccine.
The Pharma Data
NOVEMBER 27, 2020
Vaccine development to cure coronavirus is at an all-time high after Pfizer and BioNTech announced they had success with a possible vaccine candidate. UK firm develops solution for identifying whether patients are actually infectious from a virus or not. Read on to for the full insight.
World of DTC Marketing
MARCH 11, 2022
3hree: Those with higher levels of trust in healthcare are more likely to be proactive about their general health, vaccinated against COVID-19, supportive of public health measures over personal freedom, and accepting of changing recommendations from healthcare officials than are low-trusting respondents.
Pharmaceutical Technology
JULY 14, 2022
In this ongoing series , we put a spotlight on contracts between pharma companies and contract manufacturing organizations (CMOs). This analysis is based on the GlobalData Pharma Intelligence Center’s Deals database and PharmSource reports. Covid-19 vaccines stay in the spotlight.
The Pharma Data
NOVEMBER 9, 2020
In a special edition Keeping tabs round-up, Pharma IQ features the ever-anticipated news of a possible Covid-19 cure. Pfizer and BioNTech announce Covid-19 vaccine candidate success. As the Phase 3 study continues, Pfizer and BioNTech claimed the final vaccine efficacy percentage may vary.
World of DTC Marketing
MARCH 21, 2021
SUMMARY: The goal of business is to maximize profits for shareholder returns but when a company that serves the public good pays CEOs millions of dollars in compensation while having among the highest profit margins within ANY industry I would argue that something is dreadfully wrong.
pharmaphorum
FEBRUARY 16, 2021
A news agency is claiming that North Korea launched a cyber-attack on Pfizer in a bid to steal information about its BioNTech-partnered COVID-19 vaccine, citing South Korea’s National Intelligence Service (NIS). Staff are working faster, harder and longer hours than ever before,” says Jack Garnsey of cybersecurity specialist VIPRE. “In
The Pharma Data
DECEMBER 11, 2020
The University of Oxford has regularly appeared in our updates since July 2020, as its team of researchers leads an ongoing clinical trial for the Covid-19 vaccine. More recently, the university has released news of its collaboration with Thermo Fisher Scientific as it looks to discover an immune Covid-19 response pre- and post-vaccination.
World of DTC Marketing
APRIL 14, 2021
QUICK READ: Pfizer has already announced a price increase to the EU for their Covid Vaccine. The company announced last month that it expects to make $15bn (£10.9bn) off its coronavirus vaccine this year based on current deals. billion to develop one new medicine, including the cost of the many failures.”
Delveinsight
DECEMBER 15, 2020
Gannex Pharma has received Fast Track designation approval from FDA for its drug candidate ASC42 for non-alcoholic steatohepatitis (NASH). The FTA designation will help the pharma company to advance its research and development in the NASH landscape and help its commercialization in the market.
pharmaphorum
NOVEMBER 23, 2021
Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company. Sanofi is the first pharma company to partner with Baidu on its LinearDesign AI platform, which has been developed specifically to optimise the sequence of mRNA-based vaccines and drugs.
World of DTC Marketing
APRIL 7, 2021
Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Already vaccine makers are saying that we may need a Covid Vaccine booster shot every year even though there is no long term data as of yet. Walgreens Boots Alliance, Stefano Pessina — $19.2
World of DTC Marketing
JANUARY 7, 2021
Some within pharma has worked at so many jobs their resume reads like a list of pharma companies. These people tend to want titles of importance and come across as someone who would politically fit within a company. Why hasn’t Pfizer offered some help in vaccine distribution?
pharmaphorum
SEPTEMBER 22, 2021
Amnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies of for not agreeing to waive their intellectual property rights and share the technology behind them. billion doses administered worldwide, just 0.3% billion doses administered worldwide, just 0.3%
pharmaphorum
FEBRUARY 26, 2021
Centessa’s founder on the new company’s unique R&D model. Putting together a quarter-billion dollar pharma company from ten mergers in four months is not for the faint-hearted – but that’s what biotech investment guru Francesco de Rubertis has achieved with his latest project Centessa. The landscape for UK SMEs post-COVID.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content